NCT05458934 Analysis of Exhaled Breath From Patients With Lung-/Airway Diseases (BigExBrESs)
| NCT ID | NCT05458934 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Zurich |
| Condition | Lung-/Airway Diseases |
| Study Type | OBSERVATIONAL |
| Enrollment | 5,000 participants |
| Start Date | 2021-05-11 |
| Primary Completion | 2030-05 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 5,000 participants in total. It began in 2021-05-11 with a primary completion date of 2030-05.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Ananlyis of exhaled breath of patients with lung-/airway diseases to identify and distinguish respiratory diseases, and improve the disease manangament.
Eligibility Criteria
Inclusion Criteria: * Signed informed consent * Age ≥ 18 years at study entry Exclusion Criteria: * Physical or intellectual impairment precluding informed consent or protocol adherence * Known pregnancy
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05458934 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Lung-/Airway Diseases. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05458934 currently recruiting?
Yes, NCT05458934 is actively recruiting participants. Contact the research team at malcolm.kohler@usz.ch for enrollment information.
Where is the NCT05458934 trial being conducted?
This trial is being conducted at Zurich, Switzerland.
Who is sponsoring the NCT05458934 clinical trial?
NCT05458934 is sponsored by University of Zurich. The trial plans to enroll 5,000 participants.